PEGCRISANTASPASE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Investigational

Investigational

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 22:52:22 GMT 2025` Edited by `admin` on `Mon Mar 31 22:52:22 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	Y8KTZ6Y35U
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

pegcrisantaspase [INN]

Preferred Name

English

PEGCRISANTASPASE

Official Name

English

PEGYLATED ERWINIA CHRYSANTHEMI L-ASPARAGINASE

Common Name

English

ASPAREC

Brand Name

English

MPEG-R-CRISANTASPASE

Common Name

English

PEGYLATED DICKEYA CHRYSANTHEMI L-ASPARAGINASE

Common Name

English

POLYETHYLENE-GLYCOL-ERWINIA-CHRISANTHEMI-L-ASPARAGINASE

Common Name

English

Pegcrisantaspase [WHO-DD]

Common Name

English

JZP-416

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

299609

Created by admin on Mon Mar 31 22:52:22 GMT 2025 , Edited by admin on Mon Mar 31 22:52:22 GMT 2025

Code System Code Type Description

CAS

1448590-54-2

Created by admin on Mon Mar 31 22:52:22 GMT 2025 , Edited by admin on Mon Mar 31 22:52:22 GMT 2025

PRIMARY

FDA UNII

Y8KTZ6Y35U

Created by admin on Mon Mar 31 22:52:22 GMT 2025 , Edited by admin on Mon Mar 31 22:52:22 GMT 2025

PRIMARY

SMS_ID

100000166210

Created by admin on Mon Mar 31 22:52:22 GMT 2025 , Edited by admin on Mon Mar 31 22:52:22 GMT 2025

PRIMARY

EVMPD

SUB130490

Created by admin on Mon Mar 31 22:52:22 GMT 2025 , Edited by admin on Mon Mar 31 22:52:22 GMT 2025

ALTERNATIVE

INN

9991

Created by admin on Mon Mar 31 22:52:22 GMT 2025 , Edited by admin on Mon Mar 31 22:52:22 GMT 2025

PRIMARY

NCI_THESAURUS

C170297

Created by admin on Mon Mar 31 22:52:22 GMT 2025 , Edited by admin on Mon Mar 31 22:52:22 GMT 2025

PRIMARY

EVMPD

SUB180251

Created by admin on Mon Mar 31 22:52:22 GMT 2025 , Edited by admin on Mon Mar 31 22:52:22 GMT 2025

PRIMARY

Related Record Type Details


					Y8KTZ6Y35U

PEGCRISANTASPASE

ACTIVE MOIETY

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO_ACID_SUBSTITUTION	[1_3] [1_30] [1_47] [1_48] [1_53] [1_72] [1_110] [1_113] [1_145] [1_168] [1_178] [1_201] [1_219] [1_243] [1_265] [1_269] [1_318] [2_3] [2_30] [2_47] [2_48] [2_53] [2_72] [2_110] [2_113] [2_145] [2_168] [2_178] [2_201] [2_219] [2_243] [2_265] [2_269] [2_318] [3_3] [3_30] [3_47] [3_48] [3_53] [3_72] [3_110] [3_113] [3_145] [3_168] [3_178] [3_201] [3_219] [3_243] [3_265] [3_269] [3_318] [4_3] [4_30] [4_47] [4_48] [4_53] [4_72] [4_110] [4_113] [4_145] [4_168] [4_178] [4_201] [4_219] [4_243] [4_265] [4_269] [4_318]		Lys	Amount:	M-PEG-5000 N6-GLUTARIMIDE-LYSINE	SY4BX30V22
AMINO_ACID_SUBSTITUTION	[1_1] [2_1] [3_1] [4_1]		Ala	Amount:	M-PEG-5000 N6-GLUTARIMIDE-LYSINE	SY4BX30V22

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL